Patent · US Active

Method of administering amantadine prior to a sleep period

US11197835B2 · kind B2 · utility

2Cited by

119References

16Claims

0Family size

Assignee

Adamas Pharma, LLC · US

Inventors

Gregory T. Went · Mill Valley, US
Gayatri Sathyan · Bengaluru, IN
Kavita Vermani · Fremont, US
Gangadhara Ganapati · Palo Alto, US
Michael Coffee · Easton, US
Efraim Shek · Pleasanton, US
Ashok Katdare · Berkeley, US

Key dates

Filing date	Dec 26, 2019
Grant date	Dec 14, 2021
Priority date	—
Expiry date	Aug 20, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.